5. THE ROLE OF BILE ACIDS IN THE MODULATION OF APOPTOSIS

Principles of Medical Biology

Volumn 15, Issue C, 2004, Pages 119-145

  Rodrigues, Cecília M P ^a   Castro, Rui E ^a   Steer, Clifford J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957048409     PISSN: 15692582     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2582(04)15005-8     Document Type: Review

References (41)

1. Andreassen O.A., Ferrante R.J., Hughes D.B., Klivenyi P., Dedeoglu A., Ona V.O., Friedlander R.M., and Beal M.F. Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. J. Neurochem 75 (2000) 847-852
2. Azzaroli F., Mehal W., Soroka C.J., Wang L., Lee J., Crispe N., and Boyer J.L. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology 36 (2002) 49-54
3. Beuers U., Bilzer M., Chittattu A., Kullak-Ublick G.A., Keppler D., Paumgartner G., and Dombrowski F. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33 (2001) 1206-1216
4. 2+ signals in isolated rat hepatocytes. Gastroenterology 104 (1993) 604-612
5. Beuers U., Throckmorton D.C., Anderson M.S., Isales C.M., Thasler W., Kullak-Ublick G.A., Sauter G., Koebe H.G., Paumgartner G., and Boyer J.L. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 110 (1996) 1553-1563
6. Calmus Y., Gane P., Rouger P., and Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid. Hepatology 11 (1990) 12-15
7. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: Opening the X-files. Science 294 (2001) 1866-1870
8. Duan W.-M., Rodrigues C.M.P., Zhao L.R., Steer C.J., and Low W.C. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. Cell Transplant 11 (2002) 195-205
9. Faubion W.A., Guicciardi M.E., Miyoshi H., Bronk S.F., Roberts P.J., Svingen P.A., Kaufmann S.H., and Gores G.J. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest 103 (1999) 137-145
10. Fiorucci S., Mencarelli A., Palazzetti B., Del Soldato P., Morelli A., and Ignarro L.J. An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc. Natl. Acad. Sci. USA 98 (2001) 2652-2657
11. Green D.R. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 102 (2000) 1-4
12. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., and Moskowitz M.A. Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94 (1997) 2007-2012
13. Keene C.D., Rodrigues C.M.P., Eich T., Chhabra M.S., Steer C.J., and Low W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc. Natl. Acad. Sci. USA 99 (2002) 10671-10676
14. Keene C.D., Rodrigues C.M.P., Eich T., Linehan-Stieers C., Abt A., Kren B.T., Steer C.J., and Low W.C. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Exp. Neurol 171 (2001) 351-360
15. Koga H., Sakisaka S., Ohishi M., Sata M., and Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25 (1997) 1077-1084
16. Kurosawa H., Que F.G., Roberts L.R., Fesmier P.J., and Gores G.J. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am. J. Physiol 272 (1997) G1587-G1593
17. Lazaridis K.N., Gores G.J., and Lindor K.D. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J. Hepatol 35 (2001) 134-146
18. Lieser M.J., Park J., Natori S., Jones B.A., Bronk S.F., and Gores G.J. Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology 115 (1998) 693-701
19. Matsushita K., Meng W., Wang X., Asahi M., Asahi K., Moskowitz M.A., and Lo E.H. Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J. Cereb. Blood Flow Metab 20 (2000) 396-404
20. Mayne M., Ni W., Yan H.J., Xue M., Johnston J.B., Del Bigio M.R., Peeling J., and Power C. Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-α expression is neuroprotective after intracerebral hemorrhage. Stroke 32 (2001) 240-248
21. Ona V.O., Li M., Vonsattel J.P., Andrews L.J., Khan S.Q., Chung W.M., Frey A.S., Menon A.S., Li X.J., Stieg P.E., Yuan J., Penney J.B., Young A.B., Cha J.H., and Friedlander R.M. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399 (1999) 263-267
22. Paumgartner G., and Beuers U. Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited. Hepatology 36 (2002) 525-531
23. Qiao L., Studer E., Leach K., McKinstry R., Gupta S., Decker R., Kukreja R., Valerie K., Nagarkatti P., El Deiry W., Molkentin J., Schmidt-Ullrich R., Fisher P.B., Grant S., Hylemon P.B., and Dent P. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: Inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol. Biol. Cell 12 (2001) 2629-2645
24. Qiao L., Yacoub A., Studer E., Gupta S., Pei X.Y., Grant S., Hylemon P.B., and Dent P. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology 35 (2002) 779-789
25. Rodrigues C.M.P., Fan G., Ma X., Kren B.T., and Steer C.J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest 101 (1998) 2790-2799
26. Rodrigues C.M.P., Fan G., Wong P.Y., Kren B.T., and Steer C.J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med 4 (1998) 165-178
27. Rodrigues C.M.P., Ma X., Linehan-Stieers C., Fan G., Kren B.T., and Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6 (1999) 842-854
28. Rodrigues C.M.P., Solá S., Nan Z., Castro R.E., Ribeiro P.S., Low W.C., and Steer C.J. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Natl. Acad. Sci. USA 100 (2003) 6087-6092
29. Rodrigues C.M.P., Solá S., Sharpe J.C., Moura J.J., and Steer C.J. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome c release in isolated mitochondria. Biochemistry 42 (2003) 3070-3080
30. Rodrigues C.M.P., Spellman S.R., Solá S., Grande A.W., Linehan-Stieers C., Low W.C., and Steer C.J. Neuroprotection by a bile acid in an acute stroke model in the rat. J. Cereb. Blood Flow Metab 22 (2002) 463-471
31. Rodrigues C.M.P., and Steer C.J. Mitochondrial membrane perturbations in cholestasis. J. Hepatol 32 (2000) 135-141
32. Rodrigues C.M.P., Stieers C.L., Keene C.D., Ma X., Kren B.T., Low W.C., and Steer C.J. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: Evidence for a mitochondrial pathway independent of the permeability transition. J. Neurochem 75 (2000) 2368-2379
33. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem 72 (2003) 137-174
34. Rust C., Karnitz L.M., Paya C.V., Moscat J., Simari R.D., and Gores G.J. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem 275 (2000) 20210-20216
35. Schierle G.S., Hansson O., Leist M., Nicotera P., Widner H., and Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med 5 (1999) 97-100
36. Schliess F., Kurz A.K., vom Dahl S., and Haussinger D. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroenterology 113 (1997) 1306-1314
37. Solá S., Ma X., Castro R.E., Kren B.T., Steer C.J., and Rodrigues C.M.P. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in TGF-β1-induced apoptosis of rat hepatocytes. J. Biol. Chem 278 (2003) 48831-48838
38. Stravitz R.T., Vlahcevic Z.R., Gurley E.C., and Hylemon P.B. Repression of cholesterol 7 α-hydroxylase transcription by bile acids is mediated through protein kinase C in primary cultures of rat hepatocytes. J. Lipid Res 36 (1995) 1359-1369
39. Thornberry N.A., and Lazebnik Y. Caspases: Enemies within. Science 281 (2000) 1312-1316
40. Xie Q., Khaoustov V.I., Chung C.C., Sohn J., Krishnan B., Lewis D.E., and Yoffe B. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 36 (2002) 592-601
41. Yerushalmi B., Dahl R., Devereaux M.W., Gumpricht E., and Sokol R.J. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 33 (2001) 616-626